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Abstract 
This paper aims to improve understanding of the role of hospitals in the generation of 
innovations. It presents a systematic and critical review of the interdisciplinary literature that 
addresses the links between the activities of hospitals and medical innovation. It identifies 
three major research streams: studies of the contribution of medical research and clinical staff 
to innovation, analyses of novel practices developed and diffused in hospitals, and 
evolutionary studies of technical change in the context of human health care. This is a highly 
heterogeneous body of literature, in which comprehensive theoretical frameworks are rare, 
and empirical studies have tended to focus on a narrow range of hospitals’ innovation 
activities. The paper introduces and discusses a framework integrating different perspectives 
that can be used to analyze the functions performed by hospitals at the intersection with 
different partners in the health innovation system and at different stages of innovation 
trajectories. On the basis of current gaps in the literature, a research agenda is discussed for a 
relational and co-evolutionary approach to the study of hospitals as innovators.   
 
Keywords: Health-care technology, health innovation system, hospitals, medical innovation, 
user innovator  
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1. Introduction  
Studies of innovation related to human health have emerged in great abundance, on topics 
ranging from advanced biotechnology to improvements in health services. Many of these 
studies argue that hospitals are central actors in this innovation, yet these organizations are 
rarely addressed directly and explicitly in innovation studies. Instead, they are treated as 
contexts, partners, indirect selection mechanisms, and users in investigations of industrial 
development and the commercialization of science. In this paper, we focus on the role of 
hospitals in the generation of medical innovations through a systematic review of the relevant 
social science literature.  
Hospitals, in particular, university or research hospitals, are part of health innovation systems, 
which can be theorized as distributed systems because of their extensive division of labor and 
complex collaborative approach to the application of useful knowledge (Coombs et al., 2003; 
von Hippel, 1988). Hospitals perform multiple functions in health innovation systems. They 
are the major providers of health-care services. They are adopters and users of new 
technologies (thus the demand side of externally generated innovation). They are potential 
developers of processes and organizational innovations. Moreover, hospitals can be an 
integral part of the education system in which new practitioners are trained, so they can be 
loci of clinical experimentation and large R&D-performing institutions in their own right. 
Overall, they are key sites for the adoption, reproduction, and generation of medical 
knowledge.  
The role of individual doctors as innovators has been covered extensively in the history of 
medical technologies but has to be understood within a complex institutional environment and 
in relation to long-term epistemic and cultural change (Blume, 1992; Pickstone, 2001). The 
role of hospitals in the consumption and implementation of innovations—both technical and 
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clinical—has also been covered extensively in the health management, health economics, and 
health policy fields. However, despite notable exceptions (e.g., Djellal and Gallouj, 2005, 
2007; Salge, 2012; Salge and Vera, 2009), the organizational capacity of hospitals to generate 
medical innovations has been underemphasized. In this paper, we are interested in assessing 
the role of hospitals as generators of medical innovation, broadly defined as “new drugs, 
devices and clinical practices introduced over time into the provision of health care” (Consoli 
and Mina, 2009). The rise of more open models of innovation (Chesbrough, 2003, 2006; 
Dahlander and Gann, 2010) makes it even more important to focus on the specific 
contribution that hospitals make or have the potential to make in upstream innovation 
activities as leading organizations or as partners to other organizations in the medical 
industrial complex. For this reason, we are especially interested in the literature that covers 
universities, research hospitals, and academic medical centers, and their arguably growing 
importance in modern health innovation systems.  
Health-care systems comprise heterogeneous actors that perform distinct but related tasks 
(Djellal and Gallouj, 2005, 2007). Although there is a division of labor among the individual 
participants, many of the tasks performed by each agent cannot be completed without the 
contributions of other agents. Thus actor groups have multiple and mutual dependencies, 
which create the systemic quality of health innovation (Windrum and García-Goñi, 2008). 
Hospitals, particularly research or academic hospitals, become central nodes in health-care 
networks because they perform multiple roles at key intersections of the system (Anderson et 
al., 1994; Ramlogan et al., 2007). First, these organizations function as brokers among 
different domains and sources of knowledge, such as scientific, clinical, technical, and 
commercial knowledge. Second, they are bridges among different modes of learning, 
including learning through medical practice, through basic and applied research, through 
technical experimentation, and learning by adapting new technologies to local contexts 
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(Morlacchi and Nelson, 2011; Rosenberg, 2009). Third, hospitals connect health-care systems 
across stages in the innovation process as they can be involved in idea generation, 
testing/verification, implementation, and diffusion.  
Hospitals contribute to new idea generation through experiential learning in clinical practice 
and research (both basic and clinical) by identifying problems and potential solutions. They 
often do so in collaboration with universities and firms under a variety of institutional 
arrangements (Rosenberg, 2009; Schlich, 2002). The outcomes of these activities are research 
outputs, insights for new inventions, and candidates for new products and processes (Chatterji 
et al., 2008). Some of these ideas may be spun out to form the basis for new companies or are 
licensed to existing firms (French and Miller, 2012).  
Hospitals can initiate some product development activities internally, particularly 
development of new procedures, new services and organizational arrangements, and new tools 
and methods. In the product development phase, however, hospitals mostly interact with 
established firms to transfer knowledge about the clinical context in which the new product 
candidates can be used. They are then involved in testing and documenting the effectiveness, 
safety, and efficiency of new product candidates, thus influencing technology selection 
(Windrum and García-Goñi, 2008). Activities linked to learning and adaptation in the user 
context is a fundamental role for hospitals, along with development of a range of service 
innovations to support the implementation of new technology or new treatments. In addition, 
hospitals can shape opportunities for technological learning because experimental practice can 
lead to new idea generation, both as incremental improvements upon existing techniques or 
services, and as ideas for new products (Djellal and Gallouj, 2005; Metcalfe et al., 2005).  
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------------------------------------ 
Insert Figure 1 around here 
------------------------------------- 
Figure 1 describes the multiple roles that hospitals can play in the generation of novelty 
within health care and medicine, which sets the parameters for the present study. Without 
implying strict linearity in these stages or dimensions, we propose that at any point in time a 
range of parallel and stepwise innovation activities occur in relation to the organizational 
context of a hospital.  
The twin objective of the paper is to provide an overview of the state of the art in this 
interdisciplinary problem and to outline a conceptual framework that can be applied to the 
study of hospitals from an innovation system perspective. By highlighting the multiple roles 
hospitals play in distributed health innovation systems, we argue that the contribution of these 
institutions must be understood in relational and co-evolutionary terms: hospitals are sources 
of novel ideas as well as conduits for innovation generated elsewhere is the system. We argue 
that a more comprehensive perspective on the role of hospitals is important to better inform 
policy by stressing the system-level impacts hospitals have on the innovative performance of 
health-care service and manufacturing activities. 
We use a systematic review methodology and sample widely in the heterogeneous and 
multidisciplinary research literature on this topic. In the next section, we present our methods 
and data. Three thematic strands of contributions emerge that differ in their perspectives and 
levels of analysis, which are articulated in more detail in section 3. In section 4, we synthesize 
and discuss the key findings. Having identified contributions and knowledge gaps, Section 5 
concludes by highlighting emerging issues for further research.  
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2.  Review method  
The paper is based on a systematic review approach (Littell et al., 2008), which aims to make 
the literature selection and review process transparent and replicable. We started from the 
factual premise that research on hospitals and innovation spans many disciplines, empirical 
approaches, and publication channels. A highly heterogeneous body of knowledge presents 
the challenge of capturing the breadth of relevant contributions and synthesizing insights and 
main findings across several scientific domains. We address this challenge by using a 
maximum variation sampling strategy (Suri, 2014).  
To select the literature for inclusion in the literature review database, multiple searches were 
carried out on search terms such as “medical innovation,” “medical and/or health-care 
innovation systems,” and “innovation and hospitals/academic medical centers/university 
hospitals/research hospitals.” Identical searches were conducted in three databases with broad 
coverage: ISI Web of Science, Scopus, and PubMed. The first set of keyword searches was 
conducted in ISI Web of Science (WoS; on the title, keywords, and abstract) on the terms 
“innovation and hospitals,” yielding 895 publications. Identical searches were conducted in 
Scopus and PubMed to verify that the searches generated the relevant research literature, thus 
validating our research strategy. Scopus and PubMed have broader coverage of publication 
types, including also books, book chapters, and practitioner-oriented publications. The 
procedure described in Table 1 was followed for each database. In Scopus and PubMed, the 
initial searches on innovation and hospitals yielded a larger number of hits (15,072 and 505). 
In these databases, we set requirements that publications should include an abstract, and 
searches were conducted on title/abstract/keywords, to enable a replication of the search 
procedures.  
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------------------------------------ 
Insert Table 1 around here 
------------------------------------- 
As seen in Table 1, searching on the keywords “hospital” and “innovation” generates a large 
number of hits, which have to be reduced to meet review feasibility constraints. We therefore 
added a third term to narrow the scope of the search. After running the three queries, 307 
abstracts from WoS, 638 abstracts from Scopus, and 203 abstracts from PubMed were 
downloaded and reviewed—a total of 1,148 abstracts. All these abstracts were read, and a 
decision was made as to whether the text was relevant in accordance with the inclusion and 
exclusion criteria in Table 1. The procedure was applied on abstracts and then on the full text 
of all documents that matched the criteria.     
As an additional measure to ensure that we were not missing relevant publications, we also 
searched for publications that included the keywords “innovation” or “technology” in their 
title in selected journals that prior searches had identified as the four that published most 
frequently on this topic. This procedure provided information about 374 papers, of which 24 
were added to the review database after the selection procedure was applied, and another six 
to the final set of papers.   
To capture the literature that was relevant to our research interest, we defined two broad 
exclusion criteria, as described in Table 1. First, we excluded the extensive literature that 
addresses only the adoption and dissemination of innovations in the health-care context. 
Hospitals are large public organizations performing complex tasks through which they are 
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simultaneously involved in a wide range of innovation processes. They involve adoption 
choices and adaptive behaviors connected to the implementation of new medical technologies 
and managerial practices, which tend to be treated in some detail in the health-care 
management and mainstream health economics literatures. These include the adoption of new 
information and communication technology (ICT) solutions as administrative tools (e.g., 
electronic medical records), also covered rather extensively in the information systems 
literature (for an overview of ICT-mediated service innovation, see Barrett et al., 2015).  
The vast literature on the implementation of medical or administrative innovation mainly 
describes how hospitals make technology adoption decisions or use innovations generated 
outside the hospital, which does not play a role in their generation. This is not to say that 
hospitals did not have a role in developing relevant new knowledge, but that this aspect of the 
innovation process is not the specific focus of the studies excluded from our database. They 
remain relevant for understanding implementation processes, but are less relevant if our 
objective is to understand how innovations are actively generated by or jointly with hospitals. 
Articles that link implementation to the generation of innovations have been included in the 
review. The same exclusion criterion was applied to literature that describes only the 
implementation of new treatment regimes, and to literature that addresses the efficiency and 
effectiveness of new innovations, without investigating how these innovations were 
developed or how hospitals or hospital staff contributed to the generation of these 
innovations.  
The second exclusion criterion applied to the identification of relevant prior art concerned 
literature other than research papers, that is, papers that do not aim to increase scholarly 
knowledge about a particular question. This means that we included papers that present either 
new conceptual approaches or empirical studies of innovation in and by hospitals, and 
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exclude opinion pieces, teaching cases, letters, and other kinds of published items that are not 
subject to peer review. The medical domain includes many such items: they have been read as 
part of the research context, but have not been included in the final review database.  
The search processes exposed the importance of searching broadly for research literature that 
addresses the role of hospitals in innovation, because numerous approaches to the topic rooted 
in different disciplinary settings exist, and each has dedicated journals and specialist 
audiences. A wide variety of fields has published on this topic, with growing intensity over 
the past 15 years (Figure 2). 
------------------------------------ 
Insert Figure 2 around here 
----------------------------------- 
Medical innovation and innovation in hospital/clinical settings has been addressed in 
economics and management, public health, health-care policy and management, innovation 
studies, sociology, science and technology studies, as well as in several medical and health 
care–related journals. The journals that have published most frequently on the topic, however, 
are in health-care policy and management, as well as in nursing-related journals. As Table 2 
shows, there is not a great deal of overlap in top publishing journals in Scopus and ISI, except 
in the journals Health Affairs and Social Science and Medicine.  
------------------------------------ 
Insert Table 2 around here 
------------------------------------- 
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For the final set of 46 articles that matched all the inclusion criteria, further detailed analyses 
were conducted. Table 3 shows how the articles represent a variety of research questions, 
methodologies, and data. This makes it more difficult to generate a coherent picture of the 
relevant knowledge base. Most of the articles describe or analyze innovation processes or 
innovation systems in which hospitals of different kinds play vital roles. The units of analysis 
are the innovation process and the network of actors that over time have contributed to the 
development of innovations with specific resources. The role of hospitals is addressed in 
relation to other actors or complementary inputs that constitute the innovation system of 
reference. Studies addressing the role of hospitals or particular types of hospitals directly are 
rarer, and in this sample few articles deal with management of innovation in hospitals.  
There are many data collection approaches, but only a few large quantitative studies. They are 
either based on surveys of a limited number of hospitals or use bibliometric or patent data. 
The articles are mostly case studies of particular diseases, medical technologies, or hospitals. 
Fourteen articles are cross-sectional studies comparing multiple units (mainly several 
hospitals).  
In line with the review methodology that integrates both qualitative and quantitative studies 
(Suri, 2014), we coded the literature on key parameters, such as study topics, methods, and 
data sources (Table 3). We used mainly a study-oriented synthesis approach, in which we 
describe briefly the key findings of the target studies, rather than aggregate findings across the 
articles sampled. We interpret and discuss the literature, but refrain from conducting any 
quantitative meta-analysis of numerical results found in the empirical evidence: this would be 
neither possible nor advisable because of fundamental differences in the issues addressed, 
data sources used, and methodological approaches employed in the literature (Suri, 2014). 
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------------------------------------ 
Insert Table 3 around here 
------------------------------------- 
3. Three strands of literature on hospitals and innovation 
We have divided the innovation literature that deals with hospitals and innovation into three 
strands based on the main analytical units they try to describe or explain. The first group of 
studies has a micro-level focus in that it addresses the contribution of particular types of 
hospital staff to the generation of innovations. The second group addresses, either 
conceptually or empirically, hospitals’ innovation activities, based on case studies or small 
sample studies of particular institutions. It typically focuses on the role of hospitals in 
innovation by looking at innovation activities at specific hospitals or particular units at 
hospitals. The third group includes studies of technological and epistemological change in 
medicine, in which the units of analysis are networks or systems of innovation connected to 
particular problems, technologies, or areas of medical practice. On rare occasions, papers with 
a very broad scope appear in more than one group. The first group of papers tends to take a 
health-care or general management perspective. The second group is relatively more 
heterogeneous in approach and theoretical perspective, but papers share a strong focus on 
organizational features and on practices that promote innovation. The third group has a more 
coherent theoretical perspective and highlight the problem of long-term sociotechnical 
changes in medical innovation.  
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3.1 Health-care practitioners and their contribution to innovation  
Many studies focus on particular groups of individuals active at hospitals and the health-care 
industry more generally. These contributions dedicate special attention to medical doctors as 
generators of innovation in a line of research with strong links to von Hippel’s (1988) 
foundational studies of user innovation. Medical doctors and clinical staff have played a 
prominent role in the development of new treatments and devices (Chatterji et al., 2008; 
Chatterji and Fabrizio, 2013; Kesselheim et al., 2014; Smith and Sfekas, 2013; Weigel, 2011). 
These studies range from quantitative analyses of patent statistics as indicators of invention by 
practitioners (Chatterji et al., 2008; Chatterji and Fabrizio, 2013; Smith and Sfekas, 2013) to 
case studies of particular medical devices (Kesselheim et al., 2014) or drugs (Xu and 
Kesselheim, 2014).  
They generally point to two interrelated roles of medical doctors as far as innovation is 
concerned. First, the original ideas for new products emerge in clinical settings, when doctors 
find, for example, that existing devices do not solve problems or address needs satisfactorily 
in the clinical setting (Kesselheim et al., 2014). Several studies find that doctors are actively 
engaged in developing designs and early stage prototypes and experiment with different 
solutions. Utilizing information in US patent data on medical devices, Chatterji (2008), 
Chatterji et al., (2013), and Smith and Sfekas (2013) demonstrate that a substantial proportion 
of the product ideas had indeed emerged from the activity of clinicians. These papers assess 
the relevance of ideas that originated with clinicians on medical device innovation and find 
that these ideas have a significant impact on subsequent innovation. Chatterji and Fabrizio 
(2013) also show that the input from patents held by medical doctors is greater in new 
technological areas and in the generation of radical innovations. These studies also link the 
role of doctors as inventors of medical devices to their role as lead users and key partners for 
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medical device companies that further develop and commercialize medical devices (Smith 
and Sfekas, 2013), a pattern that is confirmed by the qualitative studies grouped in this 
research stream (Kesselheim et al., 2014; Weigel, 2011).  
The paper by García-Goñi et al. (2007) relaxes the exclusive focus applied in this literature to 
the role of medical doctors. This insightful study looks at both managers in health-care 
organizations and frontline personnel. It considers their motivation for engaging in innovation 
processes connected to improved service provision and compares different degrees of 
participation and of motivation among different groups of staff. Overall, their comparative 
empirical analysis of different health-care professionals in six European countries finds that 
managers are significantly more motivated and more involved than frontline personnel (even 
though their preference may arguably be more sensitive to cost and efficiency concerns).  
Finally, another contribution that widens the focus from medical doctors to other stakeholder 
groups—inside and outside health-care organizations—is the study of open innovation 
platforms by Bullinger et al. (2012). The role of patients in medical innovation is often 
highlighted as important, but rarely explicitly investigated. Bullinger et al. (2012) look into 
the idea generation phase of new products and services in health care that entails open 
communication, particularly with patients and other interested stakeholders. They find that 
patients and interest groups are active and important members of innovation communities, 
particularly in cases of rare diseases, and are both sources of adequate problem definitions as 
well as innovative solutions to these problems.  
------------------------------------ 
Insert Table 4 around here 
------------------------------------- 
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3.2 Hospitals as innovative organizations   
Approximately half the papers we analyzed address the role(s) of different kinds of hospitals 
in the generation of innovations (Table 5). A common theme across these contributions is the 
attempt to capture or conceptualize hospitals’ innovativeness, on the grounds that this is 
undertheorized and underinvestigated (Djellal and Gallouj, 2007; Salge, 2009; Windrum and 
García-Goñi, 2008). This is a perspective shared with the research literature that treats 
hospitals as “hidden” research systems (Hicks and Katz, 1996; Lander, 2013; Lander and 
Atkinson-Grosjean, 2011). A common idea in this literature is that a considerable amount of 
R&D and innovation is underestimated because they involve activities and participants that 
are not adequately captured by standard indicators, such as publications, patents, and new 
products. The development of new knowledge and ideas for new products and services 
emerges from a complex interplay among scientific units, clinical units, and commercial units 
and often involves incremental technology and process improvements through learning by 
doing, which are rather difficult to observe and measure systematically. 
As can be seen in Table 5, this research stream is rather heterogeneous in terms of key 
questions, empirical objects, and methodology/data. These papers focus on hospitals in 
general (Djellal and Gallouj, 2005; 2007), hospitals in particular regions or countries (e.g., 
French and Miller, 2012; Salge, 2012; Salge and Vera, 2009; Schutz et al., 2012; Weigel, 
2011; Wu and Hsieh, 2011) or particular kinds of hospitals, that is, academic medical centers 
(Anderson et al., 1994; Rosenberg, 2009). Within these diverse empirical contexts, a range of 
issues is explored. Several papers attempt to conceptualize hospital innovativeness (Anderson 
et al., 1994; Djellal and Gallouj, 2005, 2007; Rosenberg, 2009) or explore empirically 
hospitals’ innovation projects (Salge, 2012; Salge and Vera, 2009). Other papers emphasize 
particular innovation activities or organizational practices to support innovation, including 
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research and commercialization activities (French and Miller, 2012; Lander and Atkinson-
Grosjean, 2011; Rosenberg, 2009). A final group of papers addresses organizational features 
and practices that are conducive to innovation, developing conceptualizations, such as 
hospitals as creative and learning organizations (Dias and Escoval, 2013, 2015; Hernandez et 
al., 2013; Lee and Hong, 2014; Ugurluoglu et al., 2013; Yang, 2014).  
------------------------------------ 
Insert Table 5 around here 
------------------------------------- 
These papers also differ in the types of innovations they select and consider. Many focus on 
the role of hospitals in the generation of new or improved products (e.g., medical devices or 
new treatments/drugs) (Chatterji et al., 2008; Rosenberg, 2009; Weigel, 2011). However, the 
majority of studies in this group focus on the generation and implementation of novelty in 
medical services (treatment regimes, organizational practices, and patient care) (Schultz et al., 
2012; Thakur et al., 2012) or a combination of product and process innovations (Anderson et 
al., 1994; Djellal and Gallouj, 2005, 2007).   
Djellal and Gallouj (2005), for instance, conceptualize hospitals as service providers and 
focus on the multiple operations run by hospitals and on their outputs. Their claim is that 
innovation and improvement work can occur in all aspects of hospitals’ operations. They 
therefore propose that hospital innovation is highly diverse, encompassing administrative, 
organizational, and medical practices that are bundled together in services.  
Another example of an inclusive conceptualization of innovation is found in the work by 
Salge (2012) and Salge and Vera (2009), who draw upon the distinction between science, 
17 
 
technology, innovation (STI) and doing, using, interacting (DUI) (Jensen et al., 2007) as 
modes of learning. Based on these notions, they identify two corresponding modes of hospital 
innovativeness: science-based and practice-based. They look at the relationship between 
investment in different kinds of innovation activities and performance and hypothesize that 
investments in both science-based and practice-based innovation are beneficial to hospital 
performance. More specifically, Salge (2012) investigates the organizational factors that 
influence sustained investment in these different kinds of innovation activities (science-based 
and practice-based). The results indicate temporal persistence in innovation activities, 
particularly in investments in science-based innovations, and that these are influenced by 
specialization levels, financial slack, and the strategic direction of hospitals over time. In 
addition, Schultz et al. (2012) find that management approaches that encourage employee 
involvement have a positive effect on overall innovation portfolios (i.e., the number and range 
of innovation projects) in German hospitals.  
In line with this perspective, several papers address the question of organizational 
characteristics and practices that may promote innovation at hospitals. These papers attempt 
to map whether hospital organizations foster learning, creativity, and entrepreneurial attitudes 
among employees (Dias and Escoval, 2015; García-Goñi et al., 2007; Hernandez et al., 2013; 
Lee and Hong, 2014; Raadabadi et al., 2014) and try to identify the influence such features 
have on hospitals’ innovative capability (Ugurluoglu et al., 2012) and innovation performance 
(Dias and Escoval, 2013; Yang, 2014). The results are not conclusive but, overall, seem to 
indicate that hospitals with a strong focus on learning display higher innovation performance, 
in line with general innovation theory. Notably, however, these studies are not explicit about 
the types of innovations hospitals promote and whether these features are beneficial for the 
generation of novelty or implementation of and experimentation with innovative solutions.  
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A surprisingly small number of papers address the commercial aspects of hospital innovation 
activities. French and Miller (2012) focus on the increasing commercial ethos of Canadian 
hospitals and attempt to outline features of the “entrepreneurial hospital,” which they define 
as “one that explicitly seeks to constitute patient populations and case infrastructures as 
distinctive assets (or resources) in pursuit of entrepreneurial aims” (p. 718). According to 
these authors, the data they collected through interviews indicate increasing awareness of the 
strategic value of clinical facilities and patients as assets for research and innovation, as well 
as for commercial exploitation of promising results. This is interpreted as an indication of 
changes in value regimes oriented not only toward the improvement of human health but also 
toward wealth creation, which constitutes a cultural shift, with pervasive but not well-known 
implications.  
Despite their differences, the papers that belong to this first group of studies have the 
distinction of combining a relational view of hospitals as outward-looking organizations with 
an intra-organizational perspective with a focus on the heterogeneity of innovation activities 
and considerable differences that characterize different units involved in the generation of 
novelty at hospitals. These papers conceptualize the roles of hospitals in innovation in 
different ways. We can distinguish between papers that focus on hospitals as large and 
complex service organizations and those with a sharper focus on innovative products 
developed in a hospital context. Among the former, a key message is that hospitals perform 
multiple functions but that their role is that of system integrators across functions (Anderson, 
1994; Djellal and Gallouj, 2005; 2007; French and Miller, 2012; Rosenberg, 2009; Salge, 
2012; Salge and Vera, 2009). Among the latter papers, the focus on product innovation is 
associated with an emphasis on the role that hospitals and clinical sites play in idea generation 
and marketing, as well as implementation and post implementation improvements of new 
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medical treatments and technologies (Schultz et al., 2012; Weigel, 2011; Wu and Hsieh, 
2011).   
3.3 Hospitals’ roles in innovation processes and systems   
The last group of studies identified in our database takes a systemic and longer-term view of 
medical innovation. They build, on the one hand, on the rich research tradition in the history 
of medicine and the history of technology and, on the other, on evolutionary approaches to 
innovation systems. They consider the characteristics and dynamic interplay of actors 
endowed with different (competing and complementary) bases of competence. Several papers 
focus on understanding innovation and technological developments in medicine from the 
viewpoint of a network of individuals and organizations that share the division of innovative 
labor. These networks, which often emerge to solve particular technical problems, co-evolve 
with changes in the knowledge base and underpin changes in the structure and composition of 
medical technology markets (Mina, 2009). Analyses of problem-driven innovation processes 
represent the empirical core of these studies.  
The studies sampled for this review are only journal articles, as we used journal databases for 
literature searches. The sampled papers are closely related, however, and often based on 
historical and conceptual work in the 1990s on sociotechnical systems of medical 
technologies (Blume, 1992; Gelijns and Rosenberg, 1994; Rosenberg et al., 1995; Schlich, 
2002), often published as books, book chapters, and reports. Detailed studies of the “careers” 
(Blume, 1992) of particular cases of medical technologies (e.g., medical imaging 
technologies, cochlear implants, artificial heart valves, endoscopes) led to a number of 
empirical observations about the generation and development of technologies in medicine, 
later summarized and used as the basis for renewed theoretical efforts in a series of 
publications included in Table 6.  
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------------------------------------ 
Insert Table 6 around here 
------------------------------------- 
As Table 6 shows, several papers emphasize particular medical objects (implants, heart 
valves, lenses, endoscopes, medical imaging technologies) or medical practices (telemedicine, 
ambulatory surgery, minimally invasive therapy, electronic patient records, patient registries) 
whereas others look at innovation from the vantage point of different medical problems 
(diseases or medical conditions, such as infection with HIV, heart disease, glaucoma, 
deafness). Although the empirical basis is different, what is common is nonetheless the 
ambition to track and explore the development of knowledge, technological and medical 
solutions, over time, within these defined contexts or cases. The papers emphasize 
innovations as the development of new products but also are embedded in service delivery. 
Thus, they look at innovations as both products (technical solutions or artefacts such as 
surgical tools, drugs, or particular procedures) and services (the use of tools in treatment/care 
situations). An important point is that products and process innovations are linked and that 
product innovations entail customization and adaptation, as well as the development of 
innovations in organizations and service delivery throughout customization and adoption 
processes (Patrakaki and Klucun, 2015). Compared to the first group of papers, these studies 
are less heterogeneous and focus on similar research questions, explanatory models, and 
research strategies. In terms of the latter, the studies are descriptive, often using a combination 
of data sources to generate a comprehensive image of epistemological, technological, and 
social developments in the case context.   
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These studies view innovation as long-term problem-solving processes, in which 
collaboration between different participants and competences is a key activity (Djellal and 
Gallouj, 2005, 2007; Galbrun and Kijima, 2009, 2010; Geljins and Fendrick, 1993; Geljins 
and Rosenberg, 1994; Merito and Bonaccorsi, 2007; Metcalfe et al., 2005; Morlacchi and 
Nelson, 2011; Nelson et al., 2011; Rosenberg et al., 1995). A related focus is on how 
knowledge, technologies, markets, and institutions co-evolve over a considerable time seen ex 
post as particular trajectories of change. Human agency and creativity are drivers of 
innovation, because localized search and recombination of knowledge constitute key elements 
in problem-solving activities. However, technical changes in medicine do not involve only 
development and use of knowledge; the institutional framework, particularly regulation and 
demand formation, influence both creation and dissemination of new medical knowledge and 
medical practices (Metcalfe et al., 2005). 
Furthermore, innovation processes in medicine are seen as recursive, with considerable 
interaction among invention, development, dissemination, and the use of new knowledge and 
technology. New medical innovations develop in an incremental manner and require 
substantial adaptation in many stages, considerable feedback from users, and considerable 
post-implementation development. It is hard to separate the creation of new knowledge and 
new technologies and the dissemination and use of these technologies in medical practices 
(Barbera-Tomas and Consoli, 2012; Consoli and Mina, 2009; Consoli and Ramlogan, 2008, 
2011; Essen and Lindblad, 2013; Merito and Bonaccorsi, 2007; Mina et al., 2007; Petrakaki 
and Klecun, 2015). With this in mind, the point is made that the mainstream health-care 
management literature all too often separates implementation from innovation (Essen and 
Lindblad, 2013).  
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Morlacchi and Nelson (2011) claim that medical innovations or improved medical practices 
are the result of developments in three “co-evolving pathways”: advances in biomedical 
scientific understanding, improvement of the ability to develop new medical technologies, and 
learning in (clinical) practice. These pathways correspond in part to organizations that 
“harbor” them (universities, firms, and hospitals), but since they are also interrelated and 
recursive, fluid networks and communities (of practices) that transgress each pathway are 
equally important. Because medical innovations draw on several sources of knowledge, “rich 
ecologies” of organizations—including universities, firms, hospitals, and research institutes—
are involved in developing and dissemination of medical innovations (Nicolini, 2010; 
Ramlogan et al., 2007). At the same time, studies have also found that conflicts of interest 
between groups of professionals at hospitals and between hospitals and other organizations 
create barriers to innovation and that there is considerable resistance to developing and 
disseminating medical innovations (Blume, 1992; Nicolini, 2010). Increased specialization 
and potential intraprofessional competition, however, is also regarded as a driver for 
technological innovation in medicine (Gelijns and Rosenberg, 1994).  
Hospitals and clinical sites are fundamental components of complex health innovation 
processes (Djellal and Gallouj, 2005, 2007; Geljins and Rosenberg, 1994; Metcalfe et al., 
2005; Morlacchi and Nelson, 2011; Nelson et al., 2011; Rosenberg, 2009; Rosenberg et al., 
1995). This reflects again the importance of medical practice for identifying problems and 
solutions and points to the role of hospitals as “bridging organizations,” where different 
pathways meet and are cross-fertilized. In other words, hospitals are one of many necessary 
actors in health innovation, but they have a key brokering role in bringing actors together in 
ways that should not be taken for granted (as if all network ties were persistent over time). In 
the distributed system of actors that are involved in the generation and development of 
innovations, hospitals are often the hubs in the broader network. As seen in Table 6, most 
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papers describe multiple roles of hospitals or particular clinical sites at hospitals, ranging from 
initial idea generation to implementation and dissemination. However, in these papers, the 
hospital is not addressed as a unit. Rather, the focus is on clinical sites at hospitals, which 
have this key experimental learning and linking function intrinsically connected with 
innovation. Clearly, many of the innovations studied emerge out of medical practice, in which 
practitioners in health-care systems are involved in incremental and practice-driven 
improvement processes directed at improving conditions for patients (Essen and Lindblad, 
2013).   
As an extension of evolutionary studies of health innovation, with its focus on co-evolution 
across diverse sets of knowledge as a key to medical innovation, a system perspective of 
innovation in health and medicine is logically consistent. Among the papers included in the 
review are several attempts at conceptualizing health innovation systems in terms of 
participants and modes of interactions (Consoli and Mina, 2009; Djellal aand Gallouj, 2005, 
2007; Galbrun and Kijima, 2010; Windrum and García-Goñi, 2008).  
Consoli and Mina (2009) argue that health innovation systems consist of two broader 
domains: (1) the science and technology domain and (2) the practical domain or the health-
care delivery system, with strong interactions within across domains. Hospitals are key actors 
in both domains, as well as brokers between them. Galbrun and Kijima (2010) use the concept 
“clinical innovation system” to describe the dual role of clinical sites in medical innovation. 
They also claim that the role of hospitals and clinical staff should not be understood merely in 
terms of their role in scientific investigations, testing new products, or implementing products 
or services. Clinical staff contribute to the generation of novelty by experimenting with 
technologies in treatment situations and by developing and implementing the social 
technologies or soft innovations (e.g., treatment protocols or advice for health-care policy on 
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what solutions to procure/reimburse), which are necessary for wide-scale changes. This 
experimental function is carried out in clinical settings and makes hospitals the key arena for 
connections between science-based knowledge, technology and clinical practice, and between 
generation, selection, and dissemination of innovations.  
Windrum and García-Goñi (2008) emphasize a third domain within the system: the policy 
domain, which to a great extent contributes to shaping how innovation processes occur and 
which innovations are selected. In traditional innovation models developed for understanding 
private sector innovation, the market is the important selection mechanism. For medical 
innovations, selection is much more complex and takes place in multi-agent environments 
with multiple selection criteria. Selection is strongly influenced by policy and policy makers, 
but policy also influences idea generation and regulates how new innovation develops. But 
the policy domain does not operate in isolation: feedback from medical and scientific 
communities also shapes policy-making, as do patients and patient groups.  
The systems-oriented literature expands and supplements the micro-level investigations of 
particular cases of medical practice. The bridging role of hospitals looms even larger, not least 
because the system is large and complex with a multitude of actors that are highly different 
from one another in incentives and competence bases. In addition, these systems differ from 
related theoretical constructs that emphasize sectoral or geographic boundaries or that neglect 
the specific nature of public sector activities and the role of context-specific policy.  
4. Synthesis of findings 
The most obvious finding that emerges from our inspection of the literature is that the 
evidence base is highly heterogeneous. Relevant research has been published in several fields 
of science and various journals, and little consensus has been reached about key questions and 
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overarching analytical frameworks. Most empirical studies published on hospitals and 
innovation are implementation studies, particularly implementation of new treatment regimes, 
ICT tools, or administrative routines in hospital settings, but investigations of the role of 
hospitals more broadly in the generation of novelty is a more recent area of interest (Salge and 
Vera, 2009). Multiple case studies have appeared on particular hospitals or specific 
innovations in medical technologies, treatment regimens, and drugs (see Table 6), but few 
attempts have been made to synthesize the evidence across this largely case-based repertoire 
of empirical evidence on how hospitals promote innovation.  
Our literature review has identified three groups of studies, in which hospitals are seen as (1) 
the context of operation of innovative practitioners (a micro-level perspective), (2) the unit of 
analysis from an organizational viewpoint (a meso-level perspective), and (3) a central 
component and interface within a broader health innovation system (a more macro- or system-
oriented perspective). The first two streams of papers encompass the activity of specific 
hospitals or groups of individuals at hospitals, whereas the third focuses on problems and the 
overall system through which innovations in medicine and health care emerge, develop, and 
spread. These approaches emphasize a multitude of roles for hospitals and hospital staff in 
innovation, but differ in their focus on different phases in innovation processes and also in 
whether they focus mainly on hospital internal roles versus roles carried out in collaboration 
with external actors in the wider health innovation system.  
The different strands of literature largely emphasize different innovation activities and the 
hospitals’ roles in them. Figure 3 maps the different strands of literature onto the broad 
perspective of hospitals’ roles in innovation, as described in Figure 3.  
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------------------------------------ 
Insert Figure 3 around here 
------------------------------------- 
Figure 3 distinguishes four quadrants that represent the activities associated with different 
phases or dimensions of innovation: generation, development, verification/selection, and 
dissemination/use. The figure also distinguishes between an inner and an outer layer of 
activities, which represent, respectively, core hospital activities in innovation and innovation-
related activities that hospitals perform in support of or in collaboration with external agents 
(including firms and regulators).  
The first strand of contributions focuses on individuals or innovative practitioners and on their 
role in generating innovations in medicine and health care. As we have noted, this literature 
dedicates special attention to the role of medical doctors and looks in some detail at the role of 
clinicians as inventors, their role in developing new products, and the ways in which these 
activities are carried out in collaboration with industry.  
The literature on hospitals as innovative organizations (strand 2) is, as expected, mainly 
hospital-internal oriented (it covers the four inner quadrants). Some of this literature also has a 
particular focus on use and dissemination, particularly on the question of complementary 
service innovations, customization, and post-implementation improvements. This literature 
has a learning/organizational perspective and tends to emphasize the organizational features 
and management practices that promote openness and participation in innovation activities 
among hospital employees.  
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The literature on technological trajectories (strand 3) takes into account a broader range of 
evolutionary patterns in medical innovation processes. It adopts a theoretical perspective that 
is less explicitly focused on the internal organization of hospitals but, like strand 2, connects 
new idea generation with the development and diffusion of innovation at the system level.  
One fundamental problem that has received surprisingly little attention concerns the effects of 
technology selection and adoption on the current and future innovative capacity of hospitals. 
While technology assessment and technology adoption are well-researched themes in the field 
of health-care policy, the links between health-care policy and innovation policy are not a 
well-understood understood part of the health innovation system (Windrum and García-Goñi, 
2008). In particular, the relationship between resourcing of hospital activities (in terms of 
equipment and skills), development of clinical practice and the growth of innovation 
capabilities within the organization are interesting and important avenue for further research. 
Overall, more research is needed on a micro-level analysis of practitioners’ incentives for and 
engagement in innovation (including nurses and administrators) (Chatterji and Fabrizio, 2013; 
García-Goñi et al., 2007; Kesselheim et al., 2014), on the system-level implications of health-
care technology funding and selection (Windrum and García-Goñi, 2008), and arguably on 
the connection between the micro and the macro levels of analysis.  
Looking at the literature as a body of knowledge about hospitals and their role in medical 
innovation systems, the perspectives, empirical strategies, data, and methodologies used in 
current research have limitations. First, several studies have a relatively narrow scope and are 
often based on a limited set of empirical cases. Very few studies are based on detailed 
information across multiple hospitals. Although some notable studies are exempt from this 
(e.g., García-Goñi et al., 2007; Salge, 2012; Salge and Vera, 2009), most published work does 
not utilize administrative data from hospitals to a large extent, although a large variety of data 
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is available on investments in innovation, innovation processes, and outcomes in many 
countries and health systems.  
Second, because empirical studies have targeted particular empirical objects, theoretical 
development has also tended to focus on relatively narrow perspectives. For instance, a 
systems perspective is evident in some of this literature (Consoli and Mina, 2009; Galbrun 
and Kijma, 2010; Windrum and García-Goñi, 2008), but delineation of the boundaries of the 
system differs across studies. Much work remains to be done in conceptualizing and 
describing different participants, activities, resources, relationships, and institutional 
frameworks in health innovation systems.  
Third, the heterogeneous literature on hospitals and innovation has drawn upon conceptual 
frameworks and insights developed within the field of innovation studies to a limited extent. 
The literature on technological trajectories in health care and medicine draws on theoretical 
concepts from evolutionary studies of technology (e.g., Consoli and Mina, 2009; Metcalfe et 
al., 2002; Morlacchi and Nelson, 2011), but they have not always integrated the useful 
insights that can be derived from the application of organizational and managerial 
perspectives on innovation. The literature on hospitals as innovative organizations addresses 
hospital-internal matters and has focused on drivers of innovation, including organizational 
and management features that stimulate creativity and learning (Dias and Escoval, 2013, 
2015; García-Goñi et al., 2007; Salge, 2012; Salge and Vera, 2009). But both the innovation 
systems literature on health care and organizational studies of hospitals as innovators often 
obscure the unit of analysis and neglect, respectively, the internal or external institutional 
complexity of hospitals.  
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5. Concluding remarks and issues for further research  
Thematically, there is no shortage of issues for further research on the role of hospitals as 
innovators. First, as seen in Figure 3, further research is needed on hospitals as selection 
environment for innovations and how this is related to hospitals’ role in generation of 
innovations.  
Second, the growing and pervasive emphasis on “open” innovation models calls for a careful 
assessment of the opportunities, and the costs, that increased engagement in innovation with 
external partners can bring. Interest in open innovation models in health care, particularly on 
patients and other stakeholders’ involvement in innovation, is emerging (Bullinger et al., 
2012). The governance of collaborative innovation requires experience as well as dedicated 
resources within the organization. It also requires a good understanding and appropriate 
design of incentives for researchers and clinical staff that are compatible with the delivery of 
health-care services (Salge et al., 2015). 
Third, the capacity of hospitals to complement innovation activities carried out by external 
organizations (e.g., to collect evidence on experimentation with new drugs and devices), 
combined with the strong ties that research-intensive hospitals have with the university 
system, can dramatically increase incentives for companies to establish research facilities in 
the vicinity of hospitals in order to gain access to patients and to valuable knowledge. This 
may include the talent of graduates from research-intensive universities with strength in 
medicine and the life sciences or the intangible assets of smaller companies spun off from 
university departments and incubated in the local area (Mina and Probert, 2012). Therefore 
research hospitals can be significant factors in the location decisions of pharmaceutical and 
medical device companies.    
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Fourth, new ICT investments related to telemedicine and big data can provide new 
opportunities for learning if the information system of the health-care organization is designed 
to take full account of feedback mechanisms to guide further exploration in technology and 
practice.  
To provide a more coherent evidence-based perspective on the role of hospitals in innovation, 
empirical studies with wider coverage are needed. Compared to universities and their role in 
innovation, which have been studied intensively over the past few years, the empirical basis 
on hospitals is much weaker and the conceptual and theoretical work more heterogeneous. In 
particular, studies are needed on innovation activities at the hospital level, which can be 
accomplished by collecting survey data at either the hospital or unit level and the individual 
level or by combining survey data with administrative data. Broader empirical studies and 
stronger theoretical models are also needed to underpin emerging innovation policy focusing 
on health and to inform stakeholders (owners, managers, practitioners, and patients) about the 
challenges of innovation—or lack thereof—especially in publicly funded health-care systems.  
The literature review and analytical framework we present in this paper provide a starting 
point for further analysis of the roles of hospitals in the generation of innovation as guidelines 
that can be used to map actors, activities, relationships between actors and activities, their 
governance, and their outcomes. Because of the organizational and institutional complexity of 
hospitals, further empirical work should also look in some detail at departments, professional 
groups, and medical specialties within and across hospitals on a comparative and international 
basis.  
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Tables and Figures 
Table 1. Search terms and literature database 
Steps Search terms Hits in 
WoS 
Hits in 
Scopus 
Hits in 
PubMed 
Hits in 
five top 
journals 
1 Innovation AND hospitals AND medical 
innovation
1
  
123 (859) 147 
(15,072)  
8 (505)  
2 Medical innovation 99  414 93  
3 Innovation AND university hospitals (OR 
research hospitals OR academic medical 
center) 
85  77 102  
 Total literature database analyzed 307 638 203 374 
 Inclusion/exclusion terms (two steps)  Only new inclusions  
4 Abstracts: (a) Innovations, (b) hospitals, (c) not 
only implementation, (d) not patient effects, 
and (e) either conceptual or empirical studies 
50 15 13 24 
5 Full papers: (a) Innovations, (b) hospitals, (c) 
not only implementation, (d) not patient 
effects, and (e) either conceptual or empirical 
studies 
29 6 6 5 
WoS = World of Science. 1. Numbers in parentheses is the numbers of hits without adding the third search term “medical 
innovation” to the algorithm.  
Table 2. Top publishing journals on innovation and hospitals in Scopus and WoS 
  
Top 10 journals Scopus 
No. of 
publications 
 
Top 10 journals WoS 
No. of 
publications 
1 Hospitals Health Networks AHA 110 Health Affairs  45  
2 Health Care Management Review 61 Health Policy  29  
3 Social Science and Medicine 57 Implementation Science  25  
4 Academic Medicine 54 Social Science Medicine  22  
5 Harvard Business Review 51 BMC Health Services Research  20  
5 Healthcare Financial Management  41 Health Care Management 
Review 
 20  
7 Health Affairs 34 Journal of Nursing 
Administration 
 20  
8 Quality Management in Health Care 29 Journal of Advanced Nursing  15  
9 International Journal for Quality in 
Health Care 
28 Journal of Clinical Nursing  14  
10 Medical Care 27 Journal of Healthcare 
Management 
 13  
WoS = World of Science. 
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Table 3. Research questions, data, and methodology in the final sample (N = 46) 
Key features of the articles Number of articles 
Main research questions addressed  
Characteristics of medical innovation processes 15  
Characteristics of medical innovation systems 12 
Role/s of particular participants in medical innovation (hospitals, clinical 
staff, medical doctors) 
10 
Management and organization of medical innovation in hospitals 7 
Results/effects of medical innovation in hospitals 2 
  
Methods   
Quantitative data 17 
Qualitative data 13 
Mixed methods 8 
Conceptual  8 
  
Empirical approach  
Medical case study (targets particular areas of medical practice) 9 
Technological case study  (targets particular medical technologies) 9 
Hospital case study (targets one or more particular hospitals) 6 
Cross-sectional (targets several units, multiple hospitals/technologies) 14 
Not an empirical study  8 
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Table 4. Overview of papers on practitioners in health care and their role in innovation 
 
 
  
Paper  Empirical 
object  
Data Key issues explored Kinds of 
innovations  
Role of hospital/s 
Bullinger et 
al., 2012 
User 
involveme
nt in 
innovation 
through 
open 
innovation 
platforms 
Quantitative; 
communicati
on analysis 
Investigates the role of user 
oriented, open innovation 
platforms in health care 
Product and 
service 
innovations 
(ideas) 
Participants in 
open innovation 
(alongside other 
users) 
Chatterji & 
Fabrizio, 
2013 
Medical 
doctors in 
US 
Quantitative Investigates the contribution 
of medical doctors to 
innovation in medical devices  
Product 
innovation 
(medical devices) 
Hospital-based 
physicians: idea 
generation and 
marketing 
Chatterji et 
al., 2008 
Medical 
device 
firms 
Quantitative Investigates the effect of prior 
collaboration with medical 
doctors on innovation 
performance (new products)  
Product 
innovation 
(medical devices) 
Hospital-based 
physicians as lead 
users of medical 
devices 
García-Goñi  
et al., 2007 
Hospital 
managers 
and front 
line staff in 
six 
European 
countries 
Quantitative Investigates the perceptions 
and motivations of different 
kinds of hospital staff toward 
innovation in health-care 
services provision 
Innovation in 
service provision 
Hospital managers 
and front line 
staff, attitudes, 
motivation and 
degree of 
involvement in  
generating and 
implementing 
innovations 
Kesselheim 
et al., 2014 
Clinical 
doctors as 
“physician 
inventors” 
Qualitative Investigates the processes and 
individuals involved in 
coronary artery stents 
Product 
innovation 
Idea generation 
and early 
experimentation in 
clinical practice 
Smith & 
Sfekas, 
2013 
Medical 
devices   
Quantitative Investigates premarket 
approval applications filed by 
medical device firms and 
medical doctors contribution 
to them  
Product 
innovation 
Idea generation 
and early 
experimentation in 
clinical practice 
Xu & 
Kesselheim, 
2014 
Patents 
connected 
to stent 
technologi
es 
Quantitative Contribution to medical 
devices by medical doctors  
Product 
innovation 
Idea generation 
and early 
experimentation in 
clinical practice 
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Table 5. Overview of literature on hospitals as innovative organizations 
Paper  Empirical 
object  
Data Key issues explored Kinds of innovations  Role of hospital/s 
Anderson et 
al., 1994 
Academic 
medical centers 
in US 
Conceptual/mi
xed methods 
Roles of academic medical centers 
in innovation  
Product and process innovation 
within medicine 
Five roles for hospitals, generators of 
innovation, adoption, evaluative, 
advisory, training  
Dias & 
Escoval, 
2015 
Portuguese 
hospitals 
Mixed 
methods 
The relationship between hospitals 
as learning organizations and 
innovation performance 
Product, service and process 
innovations 
Generation and adoption of new 
medical practices 
Dias & 
Escoval, 
2015 
Portuguese 
hospitals 
Mixed 
methods 
The relationship between 
innovation and hospital 
performance  
Product, service and process 
innovations 
Generation and adoption of new 
medical practices 
Djellal & 
Gallouj, 
2005 
Hospitals Conceptual Hospitals as service providers and 
their role in innovation 
Multiple forms of innovation in 
hospitals, connected to different 
outputs and services performed 
Multiple, dependent on type of 
innovation 
Djellal & 
Gallouj, 
2007 
Hospitals  Lit. Review Discuss different perspectives on 
hospitals in innovation 
Hospital innovation as a broad 
category, includes both process, 
product and service innovations 
Multiple, dependent on type of 
innovation 
French & 
Miller, 2012 
Hospitals in a 
Canadian region 
Qualitative Introduces the concept of the 
entrepreneurial hospital 
Biomedical research and 
innovation  
Entrepreneurial, capitalizing on care 
functions to perform in innovation  
Hernandez 
et al., 2013 
Drivers of 
patient-centered 
innovations in 
health-care 
organizations 
Qualitative The process of initiating patient-
centered innovations in health care 
Organizational innovations 
intended to  make hospital 
services more patient friendly  
Generating innovations in service 
delivery, entails generating 
organizational innovations within the 
hospitals  
Hicks & 
Katz, 1996 
Collaboration 
between R&D 
performing 
sectors 
Quantitative 
bibliometric 
Hospitals as the hidden research 
system 
Research in biomedicine and 
health  
Important as a venue for research 
Lander, 
2013 
Translational 
medicine 
(immunology) 
Quantitative, 
bibliometric 
University-hospital collaboration  Research in biomedicine and 
health 
Integration  
Lander & 
Atkinson-
Grosjean, 
2011 
Hospital-based 
laboratories 
Conceptual 
and qualitative 
Hidden role of hospitals in 
innovation 
Biomedical innovation and 
translational medicine  
Integration between clinical and 
biomedical knowledge 
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Lee & 
Hong, 2014 
Hospitals in 
Korea 
Quantitative Determinants of knowledge sharing 
and innovation behavior among 
hospital staff  
New ideas, technical tools, and 
methods used within hospitals 
Generation of new ideas 
Raadabadi 
et al., 2014 
Hospitals in Iran Quantitative Cultures of entrepreneurship in 
hospitals 
Not specific  Generation and experimentation with 
new solutions 
Rosenberg, 
2009 
Academic 
medical centers 
Conceptual/ 
qualitative 
Institutionalization to support 
hybridization and linkages between 
medicine and natural sciences 
Medical product innovations  Collaboration between hospitals and 
universities in biomedical and 
medical device innovation 
Salge, 2012 English 
hospitals (NHS 
organizations) 
Quantitative Hospital investments in innovation Science and practice-based 
innovation 
Generation of innovations 
Salge & 
Vera, 2009 
English 
hospitals 
(National Health 
Service [NHS] 
organizations) 
Quantitative Linkage between innovation 
investment and clinical 
performance 
Science-based and practice-based 
innovation 
Generation of innovations 
Schultz et 
al., 2012 
German 
hospitals 
Quantitative Impact of innovation management 
of hospitals innovativeness  
Diffusion of different kinds of 
innovations; focus on medical 
process innovations/service 
innovations 
Really about diffusion? 
Thakur et 
al., 2012 
Hospital 
executives in the 
US 
Qualitative Definitions of innovations within 
health-care organizations 
Adoption of best practices Adopting and adapting new practices 
to local contexts 
Ugurluoglu 
et al., 2013 
Hospital 
managers at 250 
hospitals in 
Turkey 
Quantitative Characteristics of hospitals as 
learning organizations and its 
influence on innovation 
performance 
Introduction of new medical 
procedures 
Generation and adoption of new 
medical practices 
Weigel, 
2011 
Case study of 
one hospital in 
Germany 
Qualitative The contribution of the hospital to 
innovation in a regional medical 
device industry 
Product innovation (medical 
devices) 
Idea generation and leading partner in 
all stages of development 
Wu & 
Hsieh, 2011 
Hospitals in 
Taiwan 
Quantitative Impact of innovations on perceived 
quality of care 
Medical and administrative 
innovations (products and 
services) 
Adaption and development of 
improved services toward patients  
Yang, 2014  Hospitals in 
Taiwan 
Quantitative Determinants of innovation 
capability and performance in 
Taiwanese hospitals 
Innovative capability (ability to 
generate novelty)  
Generation and adoption of new 
medical practices 
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Table 6. Overview of papers on innovation processes and systems in health and medicine   
Paper  Empirical 
object/case 
Data Key issues explored Kinds of innovations Role of hospitals 
Barbera-Tomas & 
Consoli, 2012 
Implantable 
devices 
(artificial 
discs) 
Mixed 
methods 
Technological and scientific change 
processes focusing on developments of the 
knowledge base and technological tools 
for curing  degenerative disk diseases  
Product innovations Idea generation Clinical experimentation 
and testing 
Lead users 
Procurement decisions  and market  
Consoli & Mina, 
2009 
Cardiology 
and glaucoma  
Mixed 
methods 
Evolutionary processes of medical 
innovation, exemplified by research on 
two areas of medical practice  
Product and service 
innovations connected to 
treatment of particular 
medical conditions 
Basic and translational research, problem 
formulation, idea generation, 
experimentation and testing, lead users and 
feedback 
Consoli & 
Ramlogan, 2008; 
2011 
Glaucoma Conceptual 
Mixed 
methods 
Process of knowledge growth in an area of 
medicine 
Scientific development 
and innovations in 
medical practices in 
treating glaucoma 
Clinical research and collaborating with 
academic research units 
Essen & 
Lindblad, 2013 
Rheumatology  Qualitative Explores a practice-driven innovation 
processes connected to establishment and 
continuous improvement of a national 
rheumatology registry  
Product and service 
innovation (IT based) 
Idea generation, continuous improvement, 
users 
Galbrun & 
Kijima, 2009, 
2010 
Medical 
imaging 
technology 
Qualitative Dynamic relationships between sets of 
actors that over time foster innovation in 
medical technology  
Product innovation Experiential learning leads to innovation 
ideas and extends usage of technology,  
Lead users and testing functions, 
Gelijns & 
Fendrick, 1993 
Minimally 
invasive 
therapy 
Mixed 
methods 
Dynamics of medical innovation Products and procedures  Idea generation, experimentation and 
development of supplementary service 
innovations; complex interplay with other 
agents  
Gelijns & 
Rosenberg, 1994 
Endoscopes, 
medical 
imaging 
technologies  
Conceptual, 
qualitative 
Development of new medical 
technologies, depends on close interaction 
between producers and users, and is 
influenced by changes in regulation and 
financing of health-care services, and 
patterns of medical specialization. 
Product innovation 
(medical devices) 
Adoption and adaption of technologies 
developed elsewhere for medical purposes 
Clinical experimentation and incremental 
improvements in practice 
Merito & 
Bonaccorsi, 2007 
HIV 
treatments 
Mixed 
methods 
Co-evolution of clinical knowledge and 
technology in development of HIV 
treatments 
Product (drugs) and 
service (treatment) 
Experiential knowledge, experimentation 
and testing 
Develops the complementary social 
technologies needed for widespread 
adoption   
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Metcalfe et al., 
2005 
Intra-ocular 
lenses 
Mixed 
methods 
Dynamics of complex and distributed 
innovation processes in one area of 
medicine  
Service innovation 
(mode of 
treatment/procedure) and 
product innovations 
(implants) 
Idea generation, experimentation, 
complementary innovations, lead users, 
marketing 
Mina et al., 2007 Coronary 
artery disease  
Mixed 
methods 
Evolutionary trajectories of change; 
complex, co-evolutionary processes and 
path dependence  
Service innovation 
(mode of 
treatment/procedure) and 
product innovations 
(catheters and stents) 
Idea generation, research (clinical) and 
experimentation  
Morlacchi & 
Nelson, 2011 
Left 
ventricular 
assist device  
Qualitative Evolutionary study of innovation within 
one area of medical practice, that involved 
interplay between change in three related 
areas: medical practice, science and 
technology 
Product innovation (hart 
implant) and service 
innovation (mode of 
treatment)  
Problem formulation and idea generation, 
experimentation and testing, selection, 
develops complementary innovations 
Nelson et al., 
2011 
Mainly 
conceptual, 
some 
examples 
Conceptual Innovation as an evolutionary process 
involving learning in three domains 
Service innovations 
(innovation in treatment 
of diseases) 
Clinical practice, integration of different 
sources of knowledge 
Nicolini, 2010 Tele-
cardiology  
Qualitative Development and dissemination occur 
through network, and cannot be 
meaningfully depicted in a ordered stage-
like form. Highlights the political nature of 
health innovations 
Product innovation (tele-
monitoring) and service 
innovation (mode of 
care) 
 
Petrakaki & 
Klecun, 2015 
Electronic 
patient 
records (EPR) 
Qualitative Customization of EPR systems in local 
settings; how implementation often 
requires local organizational and service 
innovations 
Product and service 
innovations 
Adopter, but creating local customization 
and service innovations 
Ramlogan et al., 
2007 
Coronary 
artery 
glaucoma 
Quantitative Evolutionary processes of medical 
innovation, exemplified by research on 
two areas of medical practice 
Product and service 
innovations connected to 
treatment of particular 
medical conditions 
Basic and translational research, problem 
formulation, idea generation, 
experimentation and testing, lead users and 
feedback 
Windrum & 
García-Goñi, 
2008 
Ambulatory 
surgery  
Conceptual 
and 
qualitative 
Systems framework for exploring health 
service innovation 
Service innovation 
(mode of delivery of 
health services), 
organizational innovation  
and product innovation 
Developing and implementing a new mode 
of service delivery  
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Figures 
Figure 1. The roles of hospitals in innovation 
 
 
 
Figure 2. Publications on innovation AND hospitals in Scopus and WoS  (1965-2014) 
 
 
  
0
20
40
60
80
100
120
1960 1980 2000 2020
Publications in Scopus
Publications in ISI
44 
 
Figure 3. The roles of hospitals in innovation and the main foci within different strands 
of literature 
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